Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.

Zhao, Wen-Yi; Xu, Jia; Wang, Ming; Zhang, Zi-Zhen; Tu, Lin; Wang, Chao-Jie; Cao, Hui; Zhang, Zhi-Gang

Zhao, Wen-Yi; Xu, Jia; Wang, Ming; Zhang, Zi-Zhen; Tu, Lin; Wang, Chao-Jie; Cao, Hui; Zhang, Zhi-Gang.

Affiliation

Cao H; Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai, People's Republic of China. caohuishcn@hotmail.com.

BMC Gastroenterol ; 14: 105, 2014 Jun 07.

Article in En | MEDLINE | ID: mdl-24906683

Subject(s)

Antineoplastic Agents/therapeutic use; Benzamides/therapeutic use; Gastrointestinal Neoplasms/pathology; Gastrointestinal Stromal Tumors/pathology; Neoplasm Recurrence, Local; Piperazines/therapeutic use; Pyrimidines/therapeutic use; Area Under Curve; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Gastrointestinal Neoplasms/drug therapy; Gastrointestinal Stromal Tumors/drug therapy; Humans; Imatinib Mesylate; Male; Middle Aged; Mitotic Index; Multivariate Analysis; Neoplasm Invasiveness; Prognosis; Proportional Hazards Models; Risk Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Gastrointestinal Stromal Tumors / Gastrointestinal Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google